author-photo

Céline Alloux

6

Papers

52

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

To estimate or to forecast? Lessons from a comparative analysis of four Bayesian fitting methods based on nonparametric models

2021 Therapeutic Drug Monitoring
Show All
- Source
- Cite
- Save
Citations (0)
Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (20)
Pembrolizumab as first-line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC): Phase 2 results from CARSKIN.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (11)
Étude de phase II de l’administration de pembrolizumab (MK-3475) en monothérapie et en première ligne chez des patients présentant un carcinome épidermoïde cutané inopérable

2018 Annales De Dermatologie Et De Venereologie
Show All
- Source
- Cite
- Save
Citations (0)
Pembrolizumab as first line therapy in patients with unresectable squamous cell carcinoma of the skin: Interim results of the phase 2 CARSKIN trial.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (17)
CARSKIN: Pembrolizumab as first line therapy in patients with unresectable cutaneous squamous cell carcinoma (cSCC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)